1. Home
  2. PTIX vs BNRG Comparison

PTIX vs BNRG Comparison

Compare PTIX & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • BNRG
  • Stock Information
  • Founded
  • PTIX 1994
  • BNRG 2012
  • Country
  • PTIX United States
  • BNRG Israel
  • Employees
  • PTIX N/A
  • BNRG N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • PTIX Health Care
  • BNRG
  • Exchange
  • PTIX Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • PTIX 6.3M
  • BNRG 6.2M
  • IPO Year
  • PTIX 2016
  • BNRG 2022
  • Fundamental
  • Price
  • PTIX $2.76
  • BNRG $1.61
  • Analyst Decision
  • PTIX
  • BNRG
  • Analyst Count
  • PTIX 0
  • BNRG 0
  • Target Price
  • PTIX N/A
  • BNRG N/A
  • AVG Volume (30 Days)
  • PTIX 73.5K
  • BNRG 98.5K
  • Earning Date
  • PTIX 11-13-2025
  • BNRG 09-30-2025
  • Dividend Yield
  • PTIX N/A
  • BNRG N/A
  • EPS Growth
  • PTIX N/A
  • BNRG N/A
  • EPS
  • PTIX N/A
  • BNRG N/A
  • Revenue
  • PTIX N/A
  • BNRG $387,000.00
  • Revenue This Year
  • PTIX N/A
  • BNRG N/A
  • Revenue Next Year
  • PTIX N/A
  • BNRG N/A
  • P/E Ratio
  • PTIX N/A
  • BNRG N/A
  • Revenue Growth
  • PTIX N/A
  • BNRG 843.90
  • 52 Week Low
  • PTIX $2.25
  • BNRG $1.50
  • 52 Week High
  • PTIX $15.26
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 35.75
  • BNRG 40.08
  • Support Level
  • PTIX $2.85
  • BNRG $1.63
  • Resistance Level
  • PTIX $3.19
  • BNRG $1.75
  • Average True Range (ATR)
  • PTIX 0.23
  • BNRG 0.12
  • MACD
  • PTIX -0.04
  • BNRG 0.00
  • Stochastic Oscillator
  • PTIX 5.61
  • BNRG 5.56

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: